Skip to main content
OpenTrials
Completed

NCT Number: NCT07765394

A Clinical Trial to Evaluate the Effects of A Supplement on Supporting Signs of Metabolic Health

This study evaluates the effects of the Love Wellness supplement Hello Burn Activate on supporting metabolic health in adult females. The 12-week, single-arm, open-label, virtual trial will enroll 40 female participants aged 25-45 who are experiencing challenges with healthy weight management and body confidence.

All participants will take one capsule of the test product daily in the morning with their first meal. Participants will complete self-reported questionnaires at Baseline, Week 4, Week 8, and Week 12 to assess changes in perceived metabolic health, body confidence, overall health, and well-being.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Metabolic Health Body Confidence Gut Health Weight Management

Age range

25 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Citruslabs

Las Vegas, Nevada, 89101, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be female.
  • Be aged 25-45.
  • Currently experiencing issues regarding healthy weight management.
  • Currently experiencing issues regarding body confidence.
  • Currently experiencing difficulty maintaining a weight management routine.
  • Generally healthy - does not live with any uncontrolled chronic disease.
  • Willing to refrain from taking any products, prescription medications, or supplements that target metabolic health during the test period.
  • Willing to maintain their current diet, sleep schedule, and activity level for the duration of the study.
  • Resides in the United States.

Exclusion criteria

  • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including cancer, mental health disorders, history of serious illness in the last three months, history of substance abuse, or planned surgery during the study period.
  • Anyone taking a prescription GLP-1 medication, including but not limited to Ozempic, Wegovy, or Mounjaro.
  • Anyone taking a prescription anticoagulant ('blood thinner') medication.
  • Anyone taking a prescription antibiotic.
  • Anyone who drinks heavily (i.e., 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men).
  • Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
  • Anyone participating in another research study within the next 12 weeks.
  • Anyone unwilling to follow the study protocol.
  • Anyone with any allergies or sensitivities to any of the study product ingredients.

Treatment and study plan

Hello Burn Activate

Dietary Supplement

All enrolled participants take one capsule of Hello Burn Activate (containing heat-treated Bifidobacterium animalis lactis BPL1, inulin, vegetable capsule [hypromellose, water], and medium chain triglycerides) once daily in the morning with the first meal of the day for 12 weeks.

Primary outcomes

  1. Change in Perceived Metabolic Health

    Time frame: Baseline, Week 4, Week 8, and Week 12

    Self-reported assessment of overall metabolic health via self-reported questionnaire

Secondary outcomes

  1. Change in Body Confidence

    Time frame: Baseline, Week 4, Week 8, and Week 12

    Self-reported assessment of body confidence via self-reported questionnaire

  2. Change in Overall Well-Being

    Time frame: Baseline, Week 4, Week 8, and Week 12

    Self-reported assessment of overall well-being via self-reported questionnaire

  3. Change in Overall Health

    Time frame: Baseline, Week 4, Week 8, and Week 12

    Self-reported assessment of overall health via self-reported questionnaire

Sponsors and collaborators

Lead sponsor

Love Wellness

Industry

Collaborators

  • Citruslabs

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Aug 14, 2026
Registry last updated
Aug 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.